ZyCoV D
Alternative Names: Coronavirus DNA vaccine - Zydus Cadila; Novel corona virus-2019-nCov vaccine; Plasmid DNA vaccine - Zydus CadilaLatest Information Update: 07 Jan 2022
At a glance
- Originator Zydus Cadila
- Class COVID-19 vaccines; DNA vaccines; Viral vaccines
- Mechanism of Action Immunostimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
- Available For Licensing Yes
Highest Development Phases
- Registered COVID 2019 infections
Most Recent Events
- 05 Jan 2022 ZyCoV D receives Emergency Use Authorisation (EUA) from the Drug Controller General of India (DCGI) for COVID-2019 infections (Prevention, In adolescents) in India, prior to January 2022
- 23 Aug 2021 Registered for COVID-2019 infections (Prevention, In adults, In adolescents, In the elderly) in India (Intradermal)
- 23 Aug 2021 ZyCoV D receives Emergency Use Authorisation (EUA) from the Drug Controller General of India (DCGI) for COVID-2019 infections (Prevention) in India